Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT05750758
Eligibility Criteria:
Inclusion Criteria:
* ACS patients who meet the indications of percutaneous coronary intervention
* The reference diameter of the target vessel was ≥2.75mm
* Target lesions were treated with a drug-coated balloon catheter (DCB) for PCI
* According to IVUS assessment, the target lesions were dissected and accumulated medium without affecting distal blood flow
Exclusion Criteria:
* \<18 or \>60 years old
* Bridging vessels or stent restenosis
* Unable to sign written informed consent
* Female patients during pregnancy or lactation (for women who have not stopped menstruation, pregnancy test should be performed within 7 days prior to enrollment in this study)
* Antiplatelet agents and anticoagulants are not available; Have heparin, contrast agent and other allergies
* The subjects were participating in other uncompleted clinical trials
* Scheduled elective surgery
* Life expectancy is less than 1 year
* Patients with high blood risk
* Has long-term oral anticoagulant therapy adaptation
* Cardiogenic shock
* Patients with severe intraoperative dissection or hematoma requiring stent rescue
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05750758
Study Brief:
Protocol Section:
NCT05750758